Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Luteolin-7-O-alpha-L-arabinopyranosyl (1->6)-beta-D-glucopyranoside
Luteolin-7-O-alpha-L-arabinopyranosyl (1->6)-beta-D-glucopyranoside
CAS No. 52714-82-6
Luteolin-7-O-alpha-L-arabinopyranosyl (1->6)-beta-D-glucopyranoside( —— )
Catalog No. M32239 CAS No. 52714-82-6
Reference standards.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 641 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLuteolin-7-O-alpha-L-arabinopyranosyl (1->6)-beta-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionReference standards.
-
DescriptionReference standards.
-
In VitroLuteolin-7-O-α-L-arabinopyranosyl (1→6)-β-D-glucopyranoside (compound 2) shows significant antiradical activity in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay (EC50=41.4 μM).
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number52714-82-6
-
Formula Weight580.49
-
Molecular FormulaC26H28O15
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
[Pro3]-GIP (Rat)
High affinity rat GIP receptor partial agonist (Kd = 13 nM). Increases cAMP accumulation in COS-7 cells transfected with rat GIP receptor, while also acting as a competitive antagonist of GIP.
-
Acetyl shikonin
Acetylshikonin exhibits weak cytotoxicity against human umbilical vein endothelial cells (HUVECs) with IC5 of over 2 microM, exhibits the antiangiogenic and antitumorigenic effects by suppressing proliferation and angiogenic factors.
-
FEN1-IN-2
FEN1-IN-2 is a selective and potent inhibitor of flap endonuclease 1 (FEN1), inhibits FEN1 and XPG, has potential anticancer activity, and can be used to study DNA damage repair.
